Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives

The expression of estrogen receptors (ERs) in breast cancer (BC) represents a strong prognostic and predictive biomarker and directs therapeutic decisions in early and advanced stages. ER-low-positive BC, defined by the immunohistochemical (IHC) expression of ERs from 1% to 9%, constitutes a distinc...

Descripción completa

Detalles Bibliográficos
Autores principales: Malainou, Christina Panagiotis, Stachika, Nikolina, Damianou, Aikaterini Konstantina, Anastopoulos, Aristotelis, Ploumaki, Ioanna, Triantafyllou, Efthymios, Drougkas, Konstantinos, Gomatou, Georgia, Kotteas, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670665/
https://www.ncbi.nlm.nih.gov/pubmed/37999126
http://dx.doi.org/10.3390/curroncol30110706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670665/
https://www.ncbi.nlm.nih.gov/pubmed/37999126
http://dx.doi.org/10.3390/curroncol30110706

Ejemplares similares